Victor Hugo Fonseca de Jesus

14PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisRadiation therapyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 19, 2026
Neoadjuvant therapy versus upfront surgery followed by adjuvant chemotherapy in resectable or borderline resectable PDAC: a systematic review and meta-analysis of RCTs.

|Jul 29, 2024
A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?

Victor Hugo Fonseca de Jesus, Mauro Daniel Spina Donadio, Ângelo Borsarelli Carvalho de Brito

|Feb 26, 2024
Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis.

André L F Azeredo-da-Silva, Victor Hugo F de Jesus, Ion Agirrezabal

|Aug 02, 2023
HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors.

Milton J Barros, Jonathan Strosberg, Taymeyah Al-Toubah

|Apr 28, 2023
Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist's Perspective.

Victor Hugo Fonseca de Jesus, Rachel P Riechelmann

|Jan 02, 2023
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A Single-Center Retrospective Analysis.

Angelo Borsarelli Carvalho de Brito, Rachel P Riechelmann, Victor Hugo Fonseca de Jesus

Pageof 3

Frequent Collaborators

4 joint publications

Silvio Melo Torres

3 joint publications

Rachel Simões Pimenta Riechelmann

2 joint publications

Heber Salvador C Ribeiro

2 joint publications

Wilson L da Costa